Synthetic biology biotech nets three-hit combo in new financing, Bristol Myers deal and first CSO

Study will evaluate the safety, tolerability and pharmacokinetics (PK) of OCT-980 in healthy volunteers

Initiation of the study marks Octant’s transition to a clinical-stage company